FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
- Country
- Italy
- Type
- Funder
- Website
- www.istitutotumori.mi.it
- Calls awarded
- 1
- Grants received
- 57
Funding record
- 57 grants on record
- €20,245,933.55 awarded in total
- 2008–2027 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
- Horizon Europe Framework Programme
- Seventh Framework Programme
- Horizon 2020 Framework Programme
- European Research Council
- PSC MINISTERO DELLA SALUTE
14 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- INSTITUT GUSTAVE ROUSSY
- DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- KAROLINSKA INSTITUTET
- STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
- EUROPEAN CANCER ORGANISATION
- FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)
Calls from this organisation
Grants received
- Transferable Trustworthy Radiotherapy with Artificial Intelligence
- FORNITURA DI CONSUMALI PER UTILIZZO SENTIMAG
- CONTRATTO CONDIVISIONE STUDIO ONCOGREEN TRA PROF. MAZZAFERRO E PROF. PAOLO CIANA - PAZIENTI CON PERIODO DI RIFERIMENTO 19 NOVEMBRE 2025- 31 MAGGIO 2026
- Multimodal data Integration and AI-based REsearch on environmental exposures in children and Young Adult cancers
- Making patient-derived tumor organoids a reliable cancer therapy testing platform
- Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach
- Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA survivors using eXtended Reality.
- Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicity
- Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
- Risk assessment Tools for severe side Effects after breasT Radiotherapy: radiation safety through biological extended models and dIgital twinS
- Bone Marrow-on-Chip as smart sensor of lung cancer relapse
- FCAECC Fellowship programme for talented researchers in cancer
- A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA
- IMAGING AND ADVANCED GUIDANCE FOR WORKFLOW OPTIMIZATION IN INTERVENTIONAL ONCOLOGY
- COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Fonte: ANAC — Autorità Nazionale Anticorruzione, dati sui contratti pubblici (CIG). CC BY-SA 4.0 — attribution and share-alike.
Fonte: OpenCoesione — Dipartimento per le Politiche di Coesione, Presidenza del Consiglio dei Ministri. CC BY 4.0 — attribution.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.